Chartwell Pharmaceuticals
Gideon Schurder is an experienced professional with a diverse background in the pharmaceutical industry. Gideon is currently serving as a Biotech Startup Mentor at TIGA VP, a venture innovation hub that provides capital investment and mentorship programs to startup companies. Prior to this role, Gideon was the Director of Business Development at Sterling Pharma Solutions. Gideon also held the position of Senior Vice President of Strategic Alliances at Chartwell Pharmaceuticals.
Gideon's previous experience includes serving as the Senior Vice President of Corporate Development at Stereokem, where they were responsible for forging relationships with industry leaders and driving various business collaborations. Before that, they founded and served as the CEO of HeadspaceCI Ltd, a London-based information services firm specializing in pharmaceutical market research.
Gideon co-founded and served as the Commercial Director of LGM Pharma and YES Pharma Ltd, where they played a crucial role in the commercial success of these companies. Gideon also served as the Commercial and Marketing Director at L.S. Raw Materials Ltd. Overall, Gideon has a successful track record of leadership and business development in the pharmaceutical industry.
Gideon Schurder's education history begins in 1998 at Bar-Ilan University, where they pursued a Bachelor's degree in Economics and Logistics until 2001. Following that, they attended Heriot-Watt University from 2002 to 2005, where they completed a Master of Business Administration (MBA) program. In 2020, Gideon enrolled in a Company Directors Course at Bar-Ilan University, which they are currently pursuing. Although they obtained an MBA certification, no information is available regarding the institution or the specific year of completion.
This person is not in any offices
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.